Characteristics of infused subjects (n = 19)
UPN . | Age . | Sex . | Race . | Years from dx . | Adverse prognostic marker . | Prior lines . | Marrow CLL burden at enrollment visit . | Target lesion size (mm2) . | ||
---|---|---|---|---|---|---|---|---|---|---|
Cytogenetics . | Molecular . | Microscopy . | Flow . | |||||||
01 | 69 | M | W | 14.1 | Complex, including del17p | NA | 6∗ | 10 | 15 | 178 |
02 | 68 | M | W | 15.3 | Trisomy 12, t(14;19), del11q | NA | 6 | NA | 40 | 1158 |
03 | 58 | M | W | 7.3 | Del17p, c-Myc amplification | BTKC481S | 3 | 20 | 7 | 1716 |
04 | 62 | M | W | 4.9 | None | NA | 1 | 5-10 | 19 | N/A |
05 | 62 | M | W | 6.6 | Del13q, del11q | NA | 3 | 10 | 47 | Undefined |
06 | 59 | M | AA | 6.1 | Del17p, del13q | None | 3 | 10 | 9 | 628 |
07 | 56 | F | W | 16.3 | Complex, including Del17p, del13q | RB1, TP53 | 2 | 70 | 80 | Undefined |
08 | 68 | M | W | 1.1 | Complex, including del17p, del13q, del 6q | TP53 | 1 | 30 | 47 | 1471 |
09 | 76 | M | W | 14.6 | Complex, including del13q, del17p | BTKC481S | 7 | 50 | 57 | N/A |
10 | 75 | M | W | 8.7 | Complex, including del13q, del11q22 | TP53, XPO1, FBXW7 | 17∗ | 20 | 37 | 2193 |
11 | 47 | M | W | 0.8 | del17p | NA | 1 | 10 | 10 | Undefined |
12 | 62 | F | W | 7.6 | del17p, del13q, del6q | NA | 6 | 25 | 43 | 2813 |
13 | 52 | F | W | 5.9 | Complex, including del17p, trisomy 12 | None | 2 | 25 | 30 | 1075 |
15 | 42 | F | W | 1.4 | None | None | 1 | 40 | 36 | 2222 |
16 | 68 | M | W | 5.8 | Del13q, del17p | TP53 | 1 | 5 | 39 | Undefined |
17 | 76 | M | W | 25.6 | Del13q | TP53, DNMT3A, MYD88 | 2 | 5 | 24 | Undefined |
18 | 66 | M | W | 15.6 | Del 13q, del17p, monosomy 17, t(11;16) | TP53S,F3B1 | 5∗ | 21 | 36 | N/A |
19 | 55 | M | W | 0.6 | Complex, including Monosomy 17, del11q | ATM | 2 | 20 | 25 | Undefined |
20 | 66 | M | W | 3.6 | Del17p, del11q | NOTCH1, ATM | 1 | 80 | 54 | N/A |
UPN . | Age . | Sex . | Race . | Years from dx . | Adverse prognostic marker . | Prior lines . | Marrow CLL burden at enrollment visit . | Target lesion size (mm2) . | ||
---|---|---|---|---|---|---|---|---|---|---|
Cytogenetics . | Molecular . | Microscopy . | Flow . | |||||||
01 | 69 | M | W | 14.1 | Complex, including del17p | NA | 6∗ | 10 | 15 | 178 |
02 | 68 | M | W | 15.3 | Trisomy 12, t(14;19), del11q | NA | 6 | NA | 40 | 1158 |
03 | 58 | M | W | 7.3 | Del17p, c-Myc amplification | BTKC481S | 3 | 20 | 7 | 1716 |
04 | 62 | M | W | 4.9 | None | NA | 1 | 5-10 | 19 | N/A |
05 | 62 | M | W | 6.6 | Del13q, del11q | NA | 3 | 10 | 47 | Undefined |
06 | 59 | M | AA | 6.1 | Del17p, del13q | None | 3 | 10 | 9 | 628 |
07 | 56 | F | W | 16.3 | Complex, including Del17p, del13q | RB1, TP53 | 2 | 70 | 80 | Undefined |
08 | 68 | M | W | 1.1 | Complex, including del17p, del13q, del 6q | TP53 | 1 | 30 | 47 | 1471 |
09 | 76 | M | W | 14.6 | Complex, including del13q, del17p | BTKC481S | 7 | 50 | 57 | N/A |
10 | 75 | M | W | 8.7 | Complex, including del13q, del11q22 | TP53, XPO1, FBXW7 | 17∗ | 20 | 37 | 2193 |
11 | 47 | M | W | 0.8 | del17p | NA | 1 | 10 | 10 | Undefined |
12 | 62 | F | W | 7.6 | del17p, del13q, del6q | NA | 6 | 25 | 43 | 2813 |
13 | 52 | F | W | 5.9 | Complex, including del17p, trisomy 12 | None | 2 | 25 | 30 | 1075 |
15 | 42 | F | W | 1.4 | None | None | 1 | 40 | 36 | 2222 |
16 | 68 | M | W | 5.8 | Del13q, del17p | TP53 | 1 | 5 | 39 | Undefined |
17 | 76 | M | W | 25.6 | Del13q | TP53, DNMT3A, MYD88 | 2 | 5 | 24 | Undefined |
18 | 66 | M | W | 15.6 | Del 13q, del17p, monosomy 17, t(11;16) | TP53S,F3B1 | 5∗ | 21 | 36 | N/A |
19 | 55 | M | W | 0.6 | Complex, including Monosomy 17, del11q | ATM | 2 | 20 | 25 | Undefined |
20 | 66 | M | W | 3.6 | Del17p, del11q | NOTCH1, ATM | 1 | 80 | 54 | N/A |
N/A, not available; Undefined, no pathologically enlarged nodes. W, White; AA, African American.
Prior CART-19.